Technical / White Paper

Longvida® Reduces Inflammatory Biomarkers in Exercise Recovery Study

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This Technical / White Paper has been written by LEHVOSS Nutrition , and any views and opinions expressed do not necessarily reflect those of

Longvida® Reduces Inflammatory Biomarkers in Exercise Recovery Study

Longvida® contains the natural antioxidant curcumin, optimized by SLCP™ Technology to deliver free (unglucuronidated) curcumin into the blood and target tissues. This patented technology enables Longvida® to cross the blood brain barrier, delivering optimized bioavailability and the tangible health benefits associated with the yellow spice.

This February, a study conducted at the University of North Texas was published on Longvida®’s ability to reduce inflammatory and muscle damage biomarkers, following oral supplementation. After exercise induced muscle damage, subjects showed significantly smaller increases in key inflammatory biomarkers with administration of 400mg/day of Longvida® versus placebo.

Longvida® is backed by numerous studies on cognitive health and has also been studied for various health applications, including the nervous system support, and promotion of longevity. Longvida® may also help to promote joint health and flexibility, and help to modulate inflammatory responses already within the normal range. Only a 400mg clinically substantiated dose, once daily is required.
Gee Lawson is the exclusive distributor of Longvida® in Europe.

Related resources from LEHVOSS Nutrition

Show more

Supplier info centre